SEC Form 4 · accession 0001013606-18-000073
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dan Lemaitre
Director
Period of report
May 9, 2018
Accepted (ET)
May 11, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2018 | A | 46,814 | $0.00 | A | 149,735 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1100% of the time-based restricted stock unit award shall vest on May 9, 2019 and shall settle in shares of common stock.